DELAFIELD, Wis. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percentage losers.
Stocks that are making large moves like these are favorites among short-term traders because they can jump into these names and try to capture some of that massive volatility. Stocks that are making big-percentage moves either up or down are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.
Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining technical indicators with fundamental trends, discipline and sound money management, you will be well on your way to investment success.
10 Best Casino Stocks To Own For 2015: Allied World Assurance Company Holdings AG (AWH)
Allied World Assurance Company Holdings, AG operates as a specialty insurance and reinsurance company in Bermuda, Hong Kong, Ireland, Singapore, Switzerland, the United Kingdom, and the United States. It offers casualty insurance products that provide coverage for specialty type risks, such as professional liability, environmental liability, product liability, inland marine liability, healthcare liability risks, and commercial general liability products, as well as professional liability products, including policies covering directors and officers, employment practices, and fiduciary liability insurance. The company also provides a mix of errors and omissions liability coverages for various service providers comprising law firms, technology companies, insurance companies, insurance agents and brokers, and municipalities; primary and excess liability, and other casualty coverages to the healthcare industry, including hospitals and hospital systems, managed care organization s, and medical facilities, such as home care providers, specialized surgery and rehabilitation centers, and outpatient clinics; and general casualty products for a range of industries consisting of construction, real estate, public entities, retailers, manufacturing, transportation, and finance and insurance services, as well as workers compensation insurance products. In addition, it offers property insurance products covering physical property and business interruption for commercial property risks; and general property products covering risks for retail chains, real estate, manufacturers, hotels and casinos, and municipalities. Further, the company provides the reinsurance of property, general casualty, professional liability, specialty lines, property catastrophe, accident and health, and marine and aviation coverages. Allied World Assurance Company Holdings, AG was founded in 2001 and is headquartered in Baar, Switzerland.
Advisors' Opinion:- [By Rich Duprey]
Specialty insurance provider�Allied World Assurance (NYSE: AWH ) announced yesterday its second-quarter dividend of $0.50 per share, a 33% increase from the payout it made last quarter of $0.375 per share, as approved by shareholders at the annual meeting last month.
- [By , Zacks Investment Research]
Here are five�stocks that made it through this week’s screen:
AmTrust Financial (AFSI) Allied World Assurance (AWH) Chatham Lodging Trust (CLDT) Federated National Holding Co. (FNHC) Whitewave Foods (WWAV)Get the rest of the stocks on this list and start screening for these companies on your own.
10 Best Stocks For 2014: HCA Holdings Inc (HCA)
HCA Holdings, Inc. (HCA), incorporated in January 1990, is a holding company whose affiliates owns and operates hospitals and related health care entities. HCA is a health care services companies in the United States. At December 31, 2011, it operated 163 hospitals, comprised of 157 general, acute care hospitals; five psychiatric hospitals, and one rehabilitation hospital. In addition, it operated 108 freestanding surgery centers. Its operations are structured into three geographically organized groups: the National, Southwest and Central Groups. At December 31, 2011, the National Group includes 64 hospitals located in Florida, South Carolina, southern Georgia, Alaska, California, Nevada, Utah and Idaho, the Southwest Group includes 46 hospitals located in Colorado, Texas, Oklahoma and the Wichita, Kansas market, and the Central Group includes 47 hospitals located in Louisiana, Indiana, Kentucky, Tennessee, Virginia, New Hampshire, northern Georgia and the Kansas City market. The Company also operates six hospitals in England, and these facilities are included in the Corporate and other group. Its facilities are located in 20 states and England. During October 2011, the Company completed its acquisition of the Colorado Health Foundation�� (Foundation).In December 2011, it sold Palmyra Medical Center in Albany, Ga.
The Company�� general, acute care hospitals typically provide a range of services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services. Outpatient and ancillary health care services are provided by its general, acute care hospitals, freestanding surgery centers, diagnostic centers and rehabilitation facilities. Its psychiatric hospitals provide a full range of mental health care services through inpatient, partial hospitalization and outpatient settings.
The Company owns, manages or operates hospitals; freestanding surgery cente! rs; diagnostic and imaging centers; radiation and oncology therapy centers; rehabilitation and physical therapy centers, and various other facilities. At December 31, 2011, it owned and operated 157 general, acute care hospitals with 40,988 licensed beds. Most of its general, acute care hospitals provide medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services and emergency services. The general, acute care hospitals also provide outpatient services such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology and physical therapy. At December 31, 2011, it operated five psychiatric hospitals with 506 licensed beds. Its psychiatric hospitals provide therapeutic programs including child, adolescent and adult psychiatric care, adult and adolescent alcohol and drug abuse treatment and counseling.
The Company also operates outpatient health care facilities, which include freestanding ambulatory surgery centers (ASCs), freestanding emergency care facilities, diagnostic and imaging centers, comprehensive outpatient rehabilitation and physical therapy centers, outpatient radiation and oncology therapy centers and various other facilities. Most of its ASCs are operated through partnerships or limited liability companies, with majority ownership of each partnership or Limited Liability Company typically held by a general partner or subsidiary that is an affiliate of HCA. Certain of its affiliates provide a variety of management services to its health care facilities, including patient safety programs; ethics and compliance programs; national supply contracts; equipment purchasing and leasing contracts; accounting, financial and clinical systems; governmental reimbursement assistance; construction planning and coordination; information technology systems and solutions; legal counsel; human resources services; and internal audit services. Under the Medicare program, it receives reimbursement under a prospective payment system (PPS) ! for gener! al, acute care hospital inpatient services.
Advisors' Opinion:- [By Sean Williams]
History practically repeated itself just a few weeks later when the CMS reversed its decision yet again on reimbursement rates, this time for acute-care hospital providers like HCA Holdings (NYSE: HCA ) and Tenet Healthcare. Unlike with Medicare Advantage providers, there wasn't any lobbying involved, just a mere reversal of opinion to raise reimbursement rates for acute-care providers by 0.8% and 1.1% for outpatient acute-care providers. The initial assessment by the CMS had called for a drop of around 1% in reimbursement rates.�
- [By Keith Speights]
Shares of HCA Holdings (NYSE: HCA ) , the largest private operator of health care facilities, jumped more than 5%. HCA's market cap moved up by $965 million or so on Monday.
- [By Keith Speights]
HCA Holdings (NYSE: HCA ) , the nation's largest private hospital chain, embarked upon a major hiring campaign for physicians over the last few years. A key impetus behind this wave of bringing new doctors on board came from the ACO emphasis in Obamacare.
- [By Michael Calia]
HCA Holdings Inc.(HCA) said its fourth-quarter earnings rose 35% on improved revenue that masked a decline in the hospital operator’s same-facility admissions. The company projected earnings for 2014 that were below estimates.
10 Best Stocks For 2014: Constellation Brands Inc (STZ.B)
Constellation Brands, Inc., incorporated on December 4, 1972, is a producer and marketer of beer, wine and spirits with operations in the United States, Canada, Mexico, New Zealand and Italy. The Company�� beer brands include Corona Extra, Corona Light, Modelo Especial, Negra Modelo and Pacifico. Its wine brands consist of Robert Mondavi, Clos du Bois, Kim Crawford, Rex Goliath, Mark West, Franciscan Estate, Ruffino and Jackson-Triggs. The Company�� spirits brands include SVEDKA Vodka and Black Velvet Canadian Whisky. The Company has more than 100 brands in its portfolio, sales in approximately 100 countries and has about 40 facilities.
Beer
The Company imports markets and sells Mexican Beer Brands in all 50 states of the United States, which includes Corona Extra, Corona Light, Modelo Especial, Pacifico, Negra Modelo and Victoria. During the fiscal year ended February 28, 2014 (fiscal 2014), the Company had 15 imported beer brands in the United States. During fiscal 2014, the Company introduced Modelo Especial Chelada, a blend of Modelo Especial with flavors of tomato, salt and lime.
Wine and Spirits
The Company sells a range of wine brands across all categories, such as table wine, sparkling wine and dessert wine in the United States, Canada and New Zealand. Its wine produced in the United States is primarily marketed domestically and in Canada and the United Kingdom. The wine produced in Canada is primarily marketed domestically. Wine produced in New Zealand is primarily marketed in the United States, Canada, Australia, the United Kingdom and domestically. Wine produced in Italy is primarily marketed in the United States, Canada and domestically. In addition, it also exports its wine products to other world markets. Its spirits business, Svedka Vodka is imported from Sweden.
The Company sells its wine brands in the United States, which comprise its United States Focus Brands (Focus Brands) includes Arbor Mist, Inniskillin, Rex Go! liath, Black Box, Kim Crawford, Robert Mondavi, Blackstone, Mark West, Ruffino, Clos du Bois, Mount Veeder, Simi, Estancia, Nobilo, Toasted Head, Franciscan Estate, Ravenswood and Wild Horse. Its spirits brands include Black Velvet Canadian Whisky and Svedka Vodka.
Corporate Operations and Other
The Corporate Operations and Other segment includes corporate-related items, including executive management, corporate development, corporate finance, human resources, internal audit, investor relations, legal, public relations and global information technology.
The Company competes with Anheuser-Busch InBev, MillerCoors, Heineken, E&J Gallo Winery, The Wine Group, Trinchero, Treasury Wine Estates, Deutsch Family Wine & Spirits, Ste. Michelle Wine Estates, Kendall-Jackson, Andrew Peller, Kruger, Pernod Ricard, Lion Nathan, Diageo, Beam, Pernod Ricard, Bacardi and Brown-Forman.
Advisors' Opinion:- [By sandyinvestment]
As the craft beer industry has a considerable measure of room to develop, Boston Beer confronts rivalry from Molson Coors Brewing (TAP) and Constellation Brands (STZ) (STZ.B). Each of the three organizations have had great runs on the Street, however Boston Beer and Constellation Brands have been the greatest outperformers. We should investigate each of them.
10 Best Stocks For 2014: Gilead Sciences Inc.(GILD)
Gilead Sciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of life threatening diseases worldwide. Its products include Atripla, Truvada, Viread, Emtriva for the treatment of human immunodeficiency virus infection in adults; Hepsera, an oral formulation for the treatment of chronic hepatitis B; AmBisome, a amphotericin B liposome injection to treat invasive fungal infections; Letairis, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension; Ranexa for the treatment of chronic angina; Vistide, an antiviral medication for the treatment of cytomegalovirus retinitis in patients with AIDS; and Cayston, an inhaled antibiotic used as a treatment to enhance respiratory systems. The company?s products also comprise Tamiflu, an oral antiviral for the treatment and prevention of influenza A and B; Macugen, an intravitreal injection for the treatment of neovascular a ge-related macular degeneration; and Lexiscan/Rapiscan, an injection used as a pharmacologic stress agent in radionuclide myocardial perfusion imaging. Its products under the Phase III clinical trials consist of Cobicistat, a pharmacoenhancer that is under evaluation as a boosting agent for HIV medicines; Elvitegravir, an oral integrase inhibitor being evaluated as part of combination therapy for HIV; Integrase Single-Tablet, a ?Quad? regimen of elvitegravir, cobicistat, tenofovir disoproxil fumarate, and emtricitabine for the treatment of HIV/AIDS in treatment-naive patients; and Aztreonam for inhalation solution for the treatment of cystic fibrosis patients with Pseudomonas aeruginosa. The company?s Phase II clinical trials products comprise Cicletanine, Ranolazine, and Aztreonam, as well as GS 9190, GS 9256, and GS 9451. Its Phase I clinical trial products include GS 7340, GS 5885, GS 6620, GS 9620, and GS 6624. The company was founded in 1987 and is headquartered in Fost er City, California.
Advisors' Opinion:- [By Selena Maranjian]
The biggest new holdings include CapitalSource�and Gilead Sciences (NASDAQ: GILD ) . Other new holdings of interest include Energy Transfer Partners� (NYSE: ETP ) . Gilead Sciences has investors hopeful about its oral Hepatitis C drug, sofosbuvir, which has cleared four phase 3 trials and received priority-review designation from the FDA. The company is also well known for its success with HIV drugs. The stock may not look like a bargain, with a P/E ratio in the 30s, but its five-year projected earnings growth rate is around 26%.
- [By Ben Levisohn]
The Nasdaq Composite, however, rose just 0.7% to $4,276.79 this week, as the once surging index was hit hard when biotech stocks tumbled. The reason: Three Democrats sent a letter to Gilead Sciencs (GILD) expressing their bewilderment that the company could charge so much for its hepatitis C drug Sovaldi. Gilead fell 4% to $72.07 this week, while Biogen Idec (BIIB), which was added to the S&P 100, dropped 4.2% to $318.53 and Regeneron Pharmaceuticals (REGN) declined 5.5% to $310.79.
10 Best Stocks For 2014: LifePoint Hospitals Inc.(LPNT)
LifePoint Hospitals Inc., through its subsidiaries, operates general acute care hospitals in non-urban communities in the United States. The company?s hospitals provide a range of medical and surgical services comprising general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation services, and pediatric services, as well as specialized services, such as open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery. Its hospitals also offer outpatient services, including one-day surgery, laboratory, x-ray, respiratory therapy, imaging, sports medicine, and lithotripsy. As of December 31, 2009, LifePoint Hospitals owned or leased 47 hospitals with a total of 5,552 licensed beds in 17 states. The company was founded in 1997 and is headquartered in Brentwood, Tennessee. Lifepoint Hospitals Inc. (NasdaqNM:LPNT) operates independently of HCA Inc. as of May 11, 1999.
Advisors' Opinion:- [By Ben Levisohn]
Yesterday afternoon, Pennsylvania announced that it would use federal dollars to pay private insurers to cover eligible Pennsylvanians. UBS analysts A.J. Rice and Jailendra Singh think Community Health Systems (CYH), Tenet Healthcare (THC) and LifePoint Hospitals (LPNT) stand to benefit the most from the deal:
- [By Keith Speights]
The fun wasn't just limited to the big three hospital operators. Lifepoint Hospitals (NASDAQ: LPNT ) stock jumped 5% on the CMS news, reflecting a $109 million market cap expansion. Likewise, Vanguard Health Systems (NYSE: VHS ) shares climbed 5%, bumping its market cap up by�$55 million.
10 Best Stocks For 2014: Post Properties Inc. (PPS)
Post Properties, Inc., a real estate investments trust (REIT), together with its subsidiaries, engages in the development, ownership, and management of multifamily apartment communities in the United States. As of December 31, 2007, the company owned 22,578 apartment units in 63 apartment communities, including 1,747 apartment units in 2 communities held in unconsolidated entities and 2,266 apartment units in 7 communities. It is also developing and selling 535 for-sale condominium homes in 4 communities and converting 349 apartment homes into for-sale condominium homes in 2 communities. The company primarily operates in Atlanta, Georgia; Dallas, Texas; Washington, D.C.; and Tampa, Florida metropolitan areas. Post Properties has elected to be taxed as REIT under the Internal Revenue Code and would not be subject to federal income taxes, if it distributes approximately 90% of its taxable income to its shareholders. The company was founded in 1971 and is based in Atlanta, Ge orgia.
Advisors' Opinion:- [By Sally Jones] ng>Rate of Return: 30.76%
Down 6% over 12 months, Post Properties Inc., a residential REIT, has a market cap of $2.46 billion; its shares were traded at around $45.02. The tangible book value is 20.98. PPS trades with a P/E ratio of 29.00 and a P/B of 2.10. The earnings yield is 2.80%.
Guru Action: As of Sept. 30, 2013, Third Avenue Management holds 422,734 shares values at around $20.9 million.
PPS is a relatively new holding for the firm, first bought in the second quarter of 2013. The firm bought 422,734 shares at an average price of $49.04, for a loss of 8.2%.
Track historical pricing, revenue and net income since 1993:
[ Enlarge Image ]
Valley National Bancorp (VLY)
Rate of Return: 26.4%
Up 5% over 12 months, Valley National Bancorp has a market cap of $2.07 billion; its shares were traded at around $10.40. The tangible book value is 5.28. VLY trades with a P/E ratio of 14.60 and a P/B of 1.30. The earnings yield is 3.80%.
Guru Action: As of Sept. 30, 2013, Third Avenue Management holds 1,462,501 shares values at around $13.8 million.
VLY is another new holding for Third Avenue, first buying 1,462,501 shares in the second quarter of 2013, at an average price of $9.34, for a gain of 11.3%.
Track historical pricing, revenue and net income since 1990:
[ Enlarge Image ]
Brookdale Senior Living Inc. (BKD)
Rate of Return: 23.14%
Up 11% over 12 months, Brookdale Senior Living Inc. has a market cap of $3.35 billion; its shares were traded at around $26.94. The tangible book value is 5.97. BKD trades with a P/B of 3.30. The earnings yield is 1.80%.
Guru Action: As of Sept. 30, 2013, Third Avenue Management holds 658,866 shares values at around $17.429 million.
Bought in the second quarter of 2013, BKD is another new holding for Third Avenue. The firm made a new buy of 658,866 shares at an average price of $27.55, for a 2.2% loss.
Track historical pricing,
- [By Philip Springer]
Post Properties Inc. (NYSE: PPS): 14.7%
Here are the largest homebuilders and their shares’ performance so far this year:
Lennar Corp. (NYSE: LEN): -2.3%
10 Best Stocks For 2014: Agios Pharmaceuticals Inc (AGIO)
Agios Pharmaceuticals, Inc., incorporated on August 7, 2007, is a biopharmaceutical company. The Company is intend to apply its deep understanding of metabolism, coupled with the Company�� ability to create medicines that can inhibit or activate metabolic enzymes, to fundamentally change the way cancer and inborn errors of metabolism (IEMs) are treated. The Company has identified and validated novel and druggable targets in both cancer and IEMs. The Company�� two advanced cancer programs are targeting mutations in the enzymes isocitrate dehydrogenase 1 and 2, referred to as IDH1 and IDH2. The Company�� drug candidates are selective for the mutated forms of IDH1 and IDH2 found in cancer cells versus the normal forms of IDH1 and IDH2 found in all other cells.
The Company focused on developing medicines to address IEMs, with a novel approach to these orphan diseases for which no effective or disease-modifying therapy is available. The Company has also de-validated and terminated numerous programs, including many that have been reported in scientific journals. In the Company�� IEM portfolio, it uses an equally rigorous set of validation techniques.
Advisors' Opinion:- [By Ben Levisohn]
3. We see 23+ partnered pipeline assets and are most positive on Phase I/II MOR202 anti-CD38 for myeloma with data in 2015, and others such as Acceleron Pharma (XLRN), Agios Pharmaceuticals (AGIO), Epizyme (EPZM), Concert Pharmaceuticals (CNCE) (just started Phase I for next-gen Revlimid).
- [By Jake L'Ecuyer]
Shares of Agios Pharmaceuticals (NASDAQ: AGIO) got a boost, shooting up 29.08 percent to $40.84 after the company reported quarterly results.
Stage Stores (NYSE: SSI) was also up, gaining 13.47 percent to $22.41 after the company reported Q4 results and announced the sale of its Steele's off-price division to a new retail unit of Hilco Global.
- [By Jake L'Ecuyer]
Equities Trading UP
Sangamo Biosciences (NASDAQ: SGMO) shot up 16.32 percent to $22.81 announced the publication in the NEJM of the first-in-man study of genome editing using its ZFN technology. Shares of Agios Pharmaceuticals (NASDAQ: AGIO) got a boost, shooting up 27.72 percent to $40.41 after the company reported quarterly results. BJ's (NASDAQ: BJRI) was also up, gaining 21.04 percent to $33.48 after the company was upgraded toa Buy rating at Buckingham research.
No comments:
Post a Comment